31 May 2023, MELBOURNE, Australia – Australia’s sovereign pandemic preparedness has received a boost with Myrio Therapeutics Pty Ltd (Myrio), a privately-owned Australian biotechnology firm with a […]
Myrio Therapeutics Pty Ltd (Myrio) today announced ground-breaking findings published in the Journal Nature. The study, titled Therapeutic Targeting of Intracellular Oncoproteins with Peptide-Centric CAR T Cells, used […]